BRCA1 and prostate carcinoma: In the example of a family which was benefited from the multigene panel analysis, BRCA1 c.1961delA was also reported in men, demonstrating the importance of BRCA1 screening not only in women, since men with pathogenic variants in this gene have a slightly higher risk for prostate cancer and male breast cancer [31, 32].